The role of the CXCR4 cell surface chemokine receptor in glioma biology
Authors:
- 14 March 2013
- journal article
- review article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 113 (2) , 153-162
Abstract
CXCR4, a cell surface chemokine receptor, mediates cellular dissemination, invasion, and proliferation in a wide range of cancers including gliomas. It is over-expressed in glioma progenitor cells, and its protein ligand, CXCL12, has been shown to mediate a specific proliferative response in these cells thereby implicating a role for CXCR4 in glioma initiation and renewal. Given the failure of currently employed therapies to meaningfully impact prognosis in patients with high-grade gliomas, the CXCR4–CXCL12 axis represents a novel biologically relevant mechanism that could be specifically targeted for therapy. From this perspective, this review summarizes the biological effects of CXCR4 activity and its implications for glioma pathogenesis. Ultimately, the development of effective treatment approaches for malignant glioma must be based on a rational mechanistic understanding of tumor cell biology. As such, this article presents such a framework with regard to the CXCR4 pathway in glioma thereby supporting the further investigation of CXCR4 as a therapeutic target in patients with this disease.Keywords
This publication has 65 references indexed in Scilit:
- Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide AntagonistsScience, 2010
- CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progressionCancer and Metastasis Reviews, 2010
- Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100Blood, 2009
- CXCL12 increases human neural progenitor cell proliferation through Akt‐1/FOXO3a signaling pathwayJournal of Neurochemistry, 2009
- CXCR4 mediates the proliferation of glioblastoma progenitor cellsCancer Letters, 2009
- Structural Basis of CXCR4 Sulfotyrosine Recognition by the Chemokine SDF-1/CXCL12Science Signaling, 2008
- Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastasesClinical & Experimental Metastasis, 2007
- CXCR4 expression mediates glioma cell invasivenessOncogene, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar developmentNature, 1998